SlideShare uma empresa Scribd logo
1 de 36
PRINCIPLE IN DRUG USE
ADVERSE DRUG EVENT
 An adverse drug event (abbreviated ADE) refers to any
injury caused by the drug (at normal dosage and/or due to
overdose) and any harm associated with the use of the drug
(e.g. discontinuation of drug therapy).
 An adverse drug reaction (abbreviated ADR) is an
expression that describes harm associated with the use of
given medications at a normal dosage during normal use.
 ADRs are a special type of ADEs.
ADVERSE DRUG REACTION
ADRs may be classified by Cause
 Type A: Augmented pharmacologic effects
 - dose dependent and predictable
 Type B: Bizarre effects (or idiosyncratic)
 - dose independent and unpredictable
 Type C: Chronic effects
 Type D: Delayed effects
 Type E: End-of-treatment effects
 Type F: Failure of therapy
 Type G: Genetic reactions
ADVERSE DRUG REACTION
 Type A: Augmented pharmacologic effects - dose dependent and
predictable
 Drug intolerance or drug sensitivity
 Drug intolerance is uncommon and idiopathic, thus extremely difficult to
predict except in persons with a prior history or a family history of intolerance
to that specific drug and general health.
 Side effect
 secondary effect which occurs in addition to the desired therapeutic effect of
a drug or medication. Side effects may vary for each individual depending on
the person's disease state, age, weight, gender, ethnicity
Ex. NSAIDs intolerance & side effect
Intolerance:
 Its cause is believed to be variation in the metabolism of arachidonic acid.
 Symptoms include chronic rhinosinusitis with nasal
polyps, asthma, gastrointestinal ulcers, angioedema, and urticaria.
Side effect :
 NSAIDs predispose to peptic ulcers, renal failure and they can increase the
risk of hemorrhage by affecting platelet function.
ANALGESIC INTOLERANCE
ANALGESIC INTOLERANCE
Urticaria
Condition Substance
Abortion, miscarriage or
Uterine hemorrhage
misoprostol, a labor-inducing drug
Addiction many sedatives and analgesics (diazepam, morphine, etc.)
Birth defects thalidomide and isotretinoin
Bleeding of the intestine aspirin therapy, NSAIDs
Cardiovascular disease COX-2 inhibitors (i.e. rofecoxib)
Deafness and kidney failure gentamicin (an antibiotic)
Death, following sedation propofol
Depression or hepatic injury interferon
Depression tetrabenazine, rimonabant and other CB1 antagonists
Diarrhea orlistat
Erectile dysfunction many drugs, such as antidepressants
Fever vaccination
Flatulence acarbose
Glaucoma corticosteroid-based eye drops
Hair loss and anemia Chemotherapy against cancer, leukemia, etc.
Headache spinal anesthesia
Hypertension
ephedrine users, edra extractswhich prompted FDA to remove the
status of dietary supplement of eph
Impaired glucose
tolerance and diabetes
atypical antipsychotic medications, such
as clozapine and olanzapine
EXAMPLES OF ADVERSE EFFECTS ASSOCIATED
WITH SPECIFIC MEDICATIONS
EXAMPLES OF ADVERSE EFFECTS ASSOCIATED
WITH SPECIFIC MEDICATIONS
Condition Substance
Insomnia stimulants (e.g. methylphenidate, amphetamine, etc.)
Kidney stones indinavir, carbonic anhydrase inhibitors (such as topiramate)
Lactic acidosis
stavudine (an antiretroviral drug) or metformin (oral anti-diabetic
medication)
Liver failure paracetamol
Melasma and thrombosis
estrogen-containing hormonal contraception such as
the combined oral contraceptive pill
Irreversible Peripheral neuropathy fluoroquinolone medications
Rhabdomyolysis statins (a class of lipid-lowering drugs)
Seizures withdrawal from benzodiazepines
Stroke or heart attack Sildenafil when used with nitroglycerine; COX-2 inhibitors
Suicide, increased tendency antidepressants
Parkinsonism MPTP, a meperidine related drug considered highly neurotoxic
Tardive dyskinesia
long-term use of metoclopramide, cinnarizine and
many antipsychotic medications
Spontaneous Tendon rupture
fluoroquinolone drugs even occurring as late as 6 months after
treatment had been terminated.
Weight loss some antidepressants, like fluoxetine and bupropion
Weight gain
some antipsychotics (e.g. olanzapine and clozapine) and
antidepressants (mirtazapine)
ADVERSE DRUG REACTION
 Type B: Bizarre effects (or idiosyncratic) - dose independent and
unpredictable
 The proposed mechanism of most idiosyncratic drug
reactions is immune-mediated toxicity.
 To create an immune response, a foreign molecule must be
present that antibodies can bind to (i.e. the antigen) and
cellular damage must exist.
 Very often, drugs will not be immunogenic because they are
too small to bind antibodies.
 However, a drug can cause an immune response if the drug
binds a larger molecule.
 Hypersensitivity
History and testing**
HYPERSENSITIVITY
Comparison of hypersensitivity types
Type Alternative names Often mentioned disorders Mediators
I Allergy (immediate)
•Atopy
•Anaphylaxis
•Asthma
•IgE and IgG4
II Cytotoxic, antibody-dependent
•Autoimmune hemolytic anemia
•Thrombocytopenia
•Erythroblastosis fetalis
•Goodpasture's syndrome
•Membranous nephropathy
•Graves' disease *see type V explanation below
•Myasthenia Gravis *see type V explanation below
•IgM or IgG
•(Complement)
III Immune complex disease
•Serum sickness
•Arthus reaction
•Rheumatoid arthritis
•Post streptococcal glomerulonephritis
•Lupus Nephritis
•Systemic lupus erythematosus (SLE)
•Extrinsic allergic alveolitis
(Hypersensitivity pneumonitis)
•IgG
•(Complement)
IV
Delayed-type
hypersensitivity(DTH), cell-mediated
immune memory response, antibody-
independent
•Contact dermatitis
•Mantoux test
•Metal joint replacement
•Chronic transplant rejection
•Multiple sclerosis
•T-cells
V
Autoimmune disease, receptor
mediated
•Graves' disease
•Myasthenia Gravis
•IgM or IgG
•(Complement)
Coombs and Gell classification
ATOPY
 A person with atopy typically presents with one or more of the following: eczema (atopic
dermatitis), allergic rhinitis (hay fever), allergic conjunctivitis, or allergic asthma. Patients with atopy also
have a tendency to have food allergies.
eczema (atopic dermatitis)
TOXIC EPIDERMAL NECROLYSIS (TEN)
AND STEVEN JOHNSON SYNDROME (SJS)
DRUG MISUSE AND DRUG ABUSE
 Drug misuse is a term used commonly for prescription
medications with clinical efficacy but abuse potential and
known adverse effects linked to improper use, such as
psychiatric medications with sedative, anxiolytic, analgesic,
or stimulant properties.
 Substance abuse, also known as drug abuse, is a patterned
use of a substance (drug) in which the user consumes the
substance in amounts or with methods neither approved nor
advised by medical professionals.
DRUG MISUSE AND DRUG ABUSE
IN SPORT
 World Anti-Doping Agency : http://www.wada-ama.org/en/
 Prohibited At All Times
 Prohibited In-Competition
 http://www.wada-ama.org/rtecontent/document/WADAC_Thai.pdf
 S1. ANABOLIC AGENTS
 S2. PEPTIDE HORMONES, GROWTH FACTORS AND RELATED SUBSTANCES
 S3. BETA-2 AGONISTS
 S4. HORMONE AND METABOLIC MODULATORS
 S5. DIURETICS AND OTHER MASKING AGENTS
 Anabolic-Androgenic Steroids
 Anabolic steroids, technically known as anabolic-androgenic
steroids (AAS), are drugs that have similar effects
to testosterone in the body.
 They have both an anabolic effect (increasing muscular strength and
size) and an androgenic effect (masculinizing) on the user.
 They increase protein within cells, especially in skeletal muscles.
 Research clearly shows that anabolic steroids use is
associated with increased body weight and mass, altered body comp
osition, increased muscle size and
strength, increased blood volume, and increased number
of red blood cells.

a. Exogenous* AAS, including:

b. Endogenous** AAS when administered exogenously:
S1. ANABOLIC-ANDROGENIC STEROIDS
S1. ANABOLIC-ANDROGENIC STEROIDS
 1-androstenediol
 1-androstenedione
 bolandiol
 bolasterone
 boldenone
 boldione
 calusterone
 clostebol
 danazol
 dehydrochlormethyltestosterone
 desoxymethyltestosterone
 drostanolone
 ethylestrenol
 fluoxymesterone
 formebolone
 furazabol
 gestrinone
 4-hydroxytestosterone
 Mestanolone
 mesterolone
 Metenolone
 methandienone
 methandriol
 methasterone
 methyldienolone
 methyl-1-testosterone
 methylnortestosterone
 methyltestosterone
 metribolone
 mibolerone
 nandrolone
 19-norandrostenedione
 norclostebol
 norethandrolone
 Oxabolone
 oxandrolone
 oxymesterone
 oxymetholone
 prostanozol
 quinbolone
 stanozolol
 stenbolone
 1-testosterone
 tetrahydrogestrinone
 trenbolone
2013 List of Prohibited Substances and Methods
A. Exogenous* AAS, including:
S1. ANABOLIC-ANDROGENIC STEROIDS
 androstenediol (androst-5-ene-3β,17β-diol)
 androstenedione (androst-4-ene-3,17-dione)
 dihydrotestosterone (17β-hydroxy-5α-androstan-3-one)
 prasterone (dehydroepiandrosterone, DHEA, 3β-hydroxyandrost-5-en-17-one)
 testosterone
2013 List of Prohibited Substances and Methods
B. Endogenous** AAS when administered exogenously:
Other Anabolic Agents, including but not limited to:
 Clenbuterol
 selective androgen receptor modulators (SARMs)
 Tibolone
 Zeranol
 zilpatero
1. TESTOSTERONE
 It is the principal male sex hormone
and an anabolic steroid.
 In men, testosterone plays a key role
in the development of male
reproductive tissues such as
the testis and prostate as well as
promoting secondary sexual
characteristics.
 Anabolic effects include growth of muscle mass and strength, increased bone
density and strength, and stimulation of linear growth and bone maturation.
 Androgenic effects include maturation of the sex organs, particularly the penis and
the formation of the scrotum in the fetus, and after birth (usually at puberty) a
deepening of the voice, growth of the beard and axillary hair. Many of these fall into
the category of male secondary sex characteristics.
1. TESTOSTERONE
Testosterone
2. METHYLTESTOSTERONE
 Used to treat men with
a testosterone deficiency.
 17α-Methylation (upper-right corner)
enhances oral bioavailability
Methyltestosterone
3. METHANDROSTENOLONE
 Methandrostenolone also known
as metandienone or methandienone, is an
orally-effective anabolic synthetic steroid.
 17α-Methylation (upper-right corner)
enhances oral bioavailability.
 Indications: Testosterone replacement
therapy on male, hypogonadal disorder.
Methandrostenolone
4. FLUOXYMESTERONE
 Fluoxymesterone is an anabolic
steroid with strong androgenic properties.
 It has been used in the treatment of
male hypogonadism, delayed puberty in
males, and in the treatment of breast
neoplasms in women.
 It is approximately 5 times as potent
as methyltestosterone.
 No brands in Thailand.
Fluoxymesterone
5. MESTEROLONE
 Mesterolone is an orally
applicable androgen,
and DHT derivative.
 Indication & Dose :
 Reduced efficiency in middle & advanced age
due to androgen deficiency
 1 tab tid.
 After satisfactory clinical improvement try to reduce the
dose. Treatment may be continued to 1 tab once daily
or bid.
 Hypogonadism
 Max: 1-2 tab tid for several mth.
 Maintenance dose: 1 tab 2-3 times daily.
 Infertility for the improvement of sperm
quantity & quality
 1 tab bid-tid for about 90 days & repeated after at several
wk if necessary.
Mesterolone
5. MESTEROLONE
 Mesterolone had seen widespread use
in bodybuilding primarily for antiestrogenic activity
in anabolic steroid stacks.
 Most significant benefits of current Mesterolone use are
considered to be maintaining libido off-cycle and also
relatively and temporarily improving vascularity.
Mesterolone
S2. EPTIDE HORMONES, GROWTH FACTORS
AND RELATED SUBSTANCES
 The following substances and their releasing factors are prohibited:
 Erythropoiesis-Stimulating Agents
 [e.g. erythropoietin (EPO), darbepoetin (dEPO), hypoxia-inducible factor
(HIF) stabilizers, methoxy polyethylene glycol-epoetin beta (CERA),
peginesatide (Hematide)]
 Chorionic Gonadotrophin (CG) and Luteinizing Hormone (LH) in
males
 The importance of measuring hCG and luteinizing hormone (LH) in the
control of testosterone misuse.
 CG is used in sports in an attempt to avoid the hormone deficiency resulting
after anabolic steroids are discontinued. The production of testosterone,
suppressed by the use of anabolic agents, is stimulated once more.
ERYTHROPOIETIN (EPO)
 Treatment of anemia associated
w/ chronic renal failure & in cancer patients
treated w/ chemotherapy.
 Erythropoiesis-stimulating agents (ESAs) have
a history of use as blood doping agents in
endurance sports
 The overall oxygen delivery system (blood
oxygen levels, as well as heart stroke volume,
vascularization, and lung function) is one of the
major limiting factors to muscles' ability to
perform endurance exercise.
 Therefore, the primary reason athletes may use
ESAs is to improve oxygen delivery to muscles,
which directly improves their endurance
capacity.
S2. EPTIDE HORMONES, GROWTH FACTORS
AND RELATED SUBSTANCES
 The following substances and their
releasing factors are prohibited:
 Corticotrophins
 to improve strength and boost the red-
blood-cell count. A high red-blood-cell
count means that the blood can carry more
oxygen, which helps improve performance.
 Corticotrophin is used in the place of
glucocorticoids following long periods of
physical stress.
 Growth Hormone and Growth factor
group,
 The effect of reducing body fat while
simultaneously increasing muscle mass
makes the substance prone to misuse in
sports. In bodybuilding, growth hormones
are combined with anabolic agents, which
further exacerbates the risk involved in both
substance types.
S3. BETA-2 AGONISTS
 All beta-2 agonists, including all optical isomers
(e.g. d- and l-) where relevant, are prohibited
except
 inhaled salbutamol (maximum 1600 micrograms over
24 hours),
 inhaled formoterol (maximum delivered dose 54
micrograms over 24 hours) and
 salmeterol when taken by inhalation in accordance
with the manufacturers’ recommended therapeutic
regimen.
S3. BETA-2 AGONISTS
Inhaled salbutamol Inhaled formoterol
Salmeterol
S3. BETA-2 AGONISTS
 Effects:
 Beta-2 agonists have the effect of
relaxing the bronchial muscles by
stimulating the beta-2 receptors.
 In this way they alleviate the
symptoms of an asthma attack.
 Medical use:
 Beta-2 agonists are used in medicine
to treat bronchial asthma.
 A distinction is made between short-
acting substances, which are inhaled
especially during an asthma attack,
and long-acting beta-2 agonists that
are used in basic therapy to reduce
the susceptibility of muscles to
cramps.
S3. BETA-2 AGONISTS
 Misuse in sports:
 When administered in high doses,
these substances promote protein
synthesis, which in the case of
animals resulted in an increase in the
proportion of muscle mass to fat
mass.
 Athletes using these substances for
doping anticipate similar effects, as
well as a short-term enhancement
of performance due to the dilation
of bronchial passages.
 Some beta-2 agonists are prohibited
in sports. In some cases therapy for
medical reasons must be approved
by applying for a therapeutic use
exemption (TUE).
OTHER
 S4. HORMONE AND METABOLIC MODULATORS
 S5. DIURETICS AND OTHER MASKING AGENTS
WARNING SIGNS OF COMMONLY ABUSED
DRUGS
 Marijuana: Glassy, red eyes; loud talking, inappropriate laughter followed by
sleepiness; loss of interest, motivation; weight gain or loss.
 Depressants (including Xanax, Valium, GHB): Contracted pupils; drunk-like;
difficulty concentrating; clumsiness; poor judgment; slurred speech; sleepiness.
 Stimulants (including amphetamines, cocaine, crystal meth): Dilated pupils;
hyperactivity; euphoria; irritability; anxiety; excessive talking followed by
depression or excessive sleeping at odd times; may go long periods of time without
eating or sleeping; weight loss; dry mouth and nose.
 Inhalants (glues, aerosols, vapors): Watery eyes; impaired vision, memory and
thought; secretions from the nose or rashes around the nose and mouth;
headaches and nausea; appearance of intoxication; drowsiness; poor muscle
control; changes in appetite; anxiety; irritability; lots of cans/aerosols in the trash.
 Hallucinogens (LSD, PCP): Dilated pupils; bizarre and irrational behavior
including paranoia, aggression, hallucinations; mood swings; detachment from
people; absorption with self or other objects, slurred speech; confusion.
 Heroin: Contracted pupils; no response of pupils to light; needle marks; sleeping
at unusual times; sweating; vomiting; coughing, sniffling; twitching; loss of appetite.

Mais conteúdo relacionado

Semelhante a Principle Drug Use.pptx

16 Pharmacology.ppt
16 Pharmacology.ppt16 Pharmacology.ppt
16 Pharmacology.ppt
Shama
 
ADVERSE DRUG REACTION PHARMACOLOGY
ADVERSE DRUG REACTION  PHARMACOLOGY ADVERSE DRUG REACTION  PHARMACOLOGY
ADVERSE DRUG REACTION PHARMACOLOGY
Prathish13
 
Adverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practiceAdverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practice
Deepali69
 

Semelhante a Principle Drug Use.pptx (20)

16 Pharmacology.ppt
16 Pharmacology.ppt16 Pharmacology.ppt
16 Pharmacology.ppt
 
Did 1
Did 1Did 1
Did 1
 
Adverse Reactions.ppt
Adverse Reactions.pptAdverse Reactions.ppt
Adverse Reactions.ppt
 
Adverse Drug reactions and its types with examples
Adverse Drug reactions and its types with examplesAdverse Drug reactions and its types with examples
Adverse Drug reactions and its types with examples
 
ADVERSE DRUG REACTION PHARMACOLOGY
ADVERSE DRUG REACTION  PHARMACOLOGY ADVERSE DRUG REACTION  PHARMACOLOGY
ADVERSE DRUG REACTION PHARMACOLOGY
 
ADR by Mukesh Jaiswal & Somya Verma
ADR by Mukesh Jaiswal & Somya VermaADR by Mukesh Jaiswal & Somya Verma
ADR by Mukesh Jaiswal & Somya Verma
 
Carcinogenesis
Carcinogenesis Carcinogenesis
Carcinogenesis
 
5.ppt
5.ppt5.ppt
5.ppt
 
ADRs.ppt
ADRs.pptADRs.ppt
ADRs.ppt
 
OVERVIEW OF ADR.pptx
OVERVIEW OF ADR.pptxOVERVIEW OF ADR.pptx
OVERVIEW OF ADR.pptx
 
Adverse Drug Reactions.ppt
Adverse Drug Reactions.pptAdverse Drug Reactions.ppt
Adverse Drug Reactions.ppt
 
Adverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practiceAdverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practice
 
ADVERSE EFFECTS OF DRUGS
ADVERSE EFFECTS OF DRUGSADVERSE EFFECTS OF DRUGS
ADVERSE EFFECTS OF DRUGS
 
ADR.ppt arverse drug reactions power pt
ADR.ppt  arverse drug reactions power ptADR.ppt  arverse drug reactions power pt
ADR.ppt arverse drug reactions power pt
 
ADR.ppt pharmacilogy ppt of adverse drug reaction
ADR.ppt pharmacilogy ppt of adverse drug reactionADR.ppt pharmacilogy ppt of adverse drug reaction
ADR.ppt pharmacilogy ppt of adverse drug reaction
 
Adverse Drug Reactions (ADR)- Ravinandan A P
Adverse Drug Reactions (ADR)- Ravinandan  A PAdverse Drug Reactions (ADR)- Ravinandan  A P
Adverse Drug Reactions (ADR)- Ravinandan A P
 
Adverse drug reaction
Adverse   drug  reactionAdverse   drug  reaction
Adverse drug reaction
 
Adverse drug reaction sjk
Adverse drug reaction sjkAdverse drug reaction sjk
Adverse drug reaction sjk
 
4. Adverse drug reaction.pptx
4. Adverse drug reaction.pptx4. Adverse drug reaction.pptx
4. Adverse drug reaction.pptx
 
adverse drugs reaction.pptx
adverse drugs reaction.pptxadverse drugs reaction.pptx
adverse drugs reaction.pptx
 

Último

Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 

Último (20)

Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 

Principle Drug Use.pptx

  • 2. ADVERSE DRUG EVENT  An adverse drug event (abbreviated ADE) refers to any injury caused by the drug (at normal dosage and/or due to overdose) and any harm associated with the use of the drug (e.g. discontinuation of drug therapy).  An adverse drug reaction (abbreviated ADR) is an expression that describes harm associated with the use of given medications at a normal dosage during normal use.  ADRs are a special type of ADEs.
  • 3. ADVERSE DRUG REACTION ADRs may be classified by Cause  Type A: Augmented pharmacologic effects  - dose dependent and predictable  Type B: Bizarre effects (or idiosyncratic)  - dose independent and unpredictable  Type C: Chronic effects  Type D: Delayed effects  Type E: End-of-treatment effects  Type F: Failure of therapy  Type G: Genetic reactions
  • 4. ADVERSE DRUG REACTION  Type A: Augmented pharmacologic effects - dose dependent and predictable  Drug intolerance or drug sensitivity  Drug intolerance is uncommon and idiopathic, thus extremely difficult to predict except in persons with a prior history or a family history of intolerance to that specific drug and general health.  Side effect  secondary effect which occurs in addition to the desired therapeutic effect of a drug or medication. Side effects may vary for each individual depending on the person's disease state, age, weight, gender, ethnicity Ex. NSAIDs intolerance & side effect Intolerance:  Its cause is believed to be variation in the metabolism of arachidonic acid.  Symptoms include chronic rhinosinusitis with nasal polyps, asthma, gastrointestinal ulcers, angioedema, and urticaria. Side effect :  NSAIDs predispose to peptic ulcers, renal failure and they can increase the risk of hemorrhage by affecting platelet function.
  • 7. Condition Substance Abortion, miscarriage or Uterine hemorrhage misoprostol, a labor-inducing drug Addiction many sedatives and analgesics (diazepam, morphine, etc.) Birth defects thalidomide and isotretinoin Bleeding of the intestine aspirin therapy, NSAIDs Cardiovascular disease COX-2 inhibitors (i.e. rofecoxib) Deafness and kidney failure gentamicin (an antibiotic) Death, following sedation propofol Depression or hepatic injury interferon Depression tetrabenazine, rimonabant and other CB1 antagonists Diarrhea orlistat Erectile dysfunction many drugs, such as antidepressants Fever vaccination Flatulence acarbose Glaucoma corticosteroid-based eye drops Hair loss and anemia Chemotherapy against cancer, leukemia, etc. Headache spinal anesthesia Hypertension ephedrine users, edra extractswhich prompted FDA to remove the status of dietary supplement of eph Impaired glucose tolerance and diabetes atypical antipsychotic medications, such as clozapine and olanzapine EXAMPLES OF ADVERSE EFFECTS ASSOCIATED WITH SPECIFIC MEDICATIONS
  • 8. EXAMPLES OF ADVERSE EFFECTS ASSOCIATED WITH SPECIFIC MEDICATIONS Condition Substance Insomnia stimulants (e.g. methylphenidate, amphetamine, etc.) Kidney stones indinavir, carbonic anhydrase inhibitors (such as topiramate) Lactic acidosis stavudine (an antiretroviral drug) or metformin (oral anti-diabetic medication) Liver failure paracetamol Melasma and thrombosis estrogen-containing hormonal contraception such as the combined oral contraceptive pill Irreversible Peripheral neuropathy fluoroquinolone medications Rhabdomyolysis statins (a class of lipid-lowering drugs) Seizures withdrawal from benzodiazepines Stroke or heart attack Sildenafil when used with nitroglycerine; COX-2 inhibitors Suicide, increased tendency antidepressants Parkinsonism MPTP, a meperidine related drug considered highly neurotoxic Tardive dyskinesia long-term use of metoclopramide, cinnarizine and many antipsychotic medications Spontaneous Tendon rupture fluoroquinolone drugs even occurring as late as 6 months after treatment had been terminated. Weight loss some antidepressants, like fluoxetine and bupropion Weight gain some antipsychotics (e.g. olanzapine and clozapine) and antidepressants (mirtazapine)
  • 9. ADVERSE DRUG REACTION  Type B: Bizarre effects (or idiosyncratic) - dose independent and unpredictable  The proposed mechanism of most idiosyncratic drug reactions is immune-mediated toxicity.  To create an immune response, a foreign molecule must be present that antibodies can bind to (i.e. the antigen) and cellular damage must exist.  Very often, drugs will not be immunogenic because they are too small to bind antibodies.  However, a drug can cause an immune response if the drug binds a larger molecule.  Hypersensitivity History and testing**
  • 10.
  • 11. HYPERSENSITIVITY Comparison of hypersensitivity types Type Alternative names Often mentioned disorders Mediators I Allergy (immediate) •Atopy •Anaphylaxis •Asthma •IgE and IgG4 II Cytotoxic, antibody-dependent •Autoimmune hemolytic anemia •Thrombocytopenia •Erythroblastosis fetalis •Goodpasture's syndrome •Membranous nephropathy •Graves' disease *see type V explanation below •Myasthenia Gravis *see type V explanation below •IgM or IgG •(Complement) III Immune complex disease •Serum sickness •Arthus reaction •Rheumatoid arthritis •Post streptococcal glomerulonephritis •Lupus Nephritis •Systemic lupus erythematosus (SLE) •Extrinsic allergic alveolitis (Hypersensitivity pneumonitis) •IgG •(Complement) IV Delayed-type hypersensitivity(DTH), cell-mediated immune memory response, antibody- independent •Contact dermatitis •Mantoux test •Metal joint replacement •Chronic transplant rejection •Multiple sclerosis •T-cells V Autoimmune disease, receptor mediated •Graves' disease •Myasthenia Gravis •IgM or IgG •(Complement) Coombs and Gell classification
  • 12. ATOPY  A person with atopy typically presents with one or more of the following: eczema (atopic dermatitis), allergic rhinitis (hay fever), allergic conjunctivitis, or allergic asthma. Patients with atopy also have a tendency to have food allergies. eczema (atopic dermatitis)
  • 13.
  • 14.
  • 15. TOXIC EPIDERMAL NECROLYSIS (TEN) AND STEVEN JOHNSON SYNDROME (SJS)
  • 16. DRUG MISUSE AND DRUG ABUSE  Drug misuse is a term used commonly for prescription medications with clinical efficacy but abuse potential and known adverse effects linked to improper use, such as psychiatric medications with sedative, anxiolytic, analgesic, or stimulant properties.  Substance abuse, also known as drug abuse, is a patterned use of a substance (drug) in which the user consumes the substance in amounts or with methods neither approved nor advised by medical professionals.
  • 17. DRUG MISUSE AND DRUG ABUSE IN SPORT  World Anti-Doping Agency : http://www.wada-ama.org/en/  Prohibited At All Times  Prohibited In-Competition  http://www.wada-ama.org/rtecontent/document/WADAC_Thai.pdf  S1. ANABOLIC AGENTS  S2. PEPTIDE HORMONES, GROWTH FACTORS AND RELATED SUBSTANCES  S3. BETA-2 AGONISTS  S4. HORMONE AND METABOLIC MODULATORS  S5. DIURETICS AND OTHER MASKING AGENTS
  • 18.  Anabolic-Androgenic Steroids  Anabolic steroids, technically known as anabolic-androgenic steroids (AAS), are drugs that have similar effects to testosterone in the body.  They have both an anabolic effect (increasing muscular strength and size) and an androgenic effect (masculinizing) on the user.  They increase protein within cells, especially in skeletal muscles.  Research clearly shows that anabolic steroids use is associated with increased body weight and mass, altered body comp osition, increased muscle size and strength, increased blood volume, and increased number of red blood cells.  a. Exogenous* AAS, including:  b. Endogenous** AAS when administered exogenously: S1. ANABOLIC-ANDROGENIC STEROIDS
  • 19. S1. ANABOLIC-ANDROGENIC STEROIDS  1-androstenediol  1-androstenedione  bolandiol  bolasterone  boldenone  boldione  calusterone  clostebol  danazol  dehydrochlormethyltestosterone  desoxymethyltestosterone  drostanolone  ethylestrenol  fluoxymesterone  formebolone  furazabol  gestrinone  4-hydroxytestosterone  Mestanolone  mesterolone  Metenolone  methandienone  methandriol  methasterone  methyldienolone  methyl-1-testosterone  methylnortestosterone  methyltestosterone  metribolone  mibolerone  nandrolone  19-norandrostenedione  norclostebol  norethandrolone  Oxabolone  oxandrolone  oxymesterone  oxymetholone  prostanozol  quinbolone  stanozolol  stenbolone  1-testosterone  tetrahydrogestrinone  trenbolone 2013 List of Prohibited Substances and Methods A. Exogenous* AAS, including:
  • 20. S1. ANABOLIC-ANDROGENIC STEROIDS  androstenediol (androst-5-ene-3β,17β-diol)  androstenedione (androst-4-ene-3,17-dione)  dihydrotestosterone (17β-hydroxy-5α-androstan-3-one)  prasterone (dehydroepiandrosterone, DHEA, 3β-hydroxyandrost-5-en-17-one)  testosterone 2013 List of Prohibited Substances and Methods B. Endogenous** AAS when administered exogenously: Other Anabolic Agents, including but not limited to:  Clenbuterol  selective androgen receptor modulators (SARMs)  Tibolone  Zeranol  zilpatero
  • 21. 1. TESTOSTERONE  It is the principal male sex hormone and an anabolic steroid.  In men, testosterone plays a key role in the development of male reproductive tissues such as the testis and prostate as well as promoting secondary sexual characteristics.  Anabolic effects include growth of muscle mass and strength, increased bone density and strength, and stimulation of linear growth and bone maturation.  Androgenic effects include maturation of the sex organs, particularly the penis and the formation of the scrotum in the fetus, and after birth (usually at puberty) a deepening of the voice, growth of the beard and axillary hair. Many of these fall into the category of male secondary sex characteristics.
  • 23. 2. METHYLTESTOSTERONE  Used to treat men with a testosterone deficiency.  17α-Methylation (upper-right corner) enhances oral bioavailability Methyltestosterone
  • 24. 3. METHANDROSTENOLONE  Methandrostenolone also known as metandienone or methandienone, is an orally-effective anabolic synthetic steroid.  17α-Methylation (upper-right corner) enhances oral bioavailability.  Indications: Testosterone replacement therapy on male, hypogonadal disorder. Methandrostenolone
  • 25. 4. FLUOXYMESTERONE  Fluoxymesterone is an anabolic steroid with strong androgenic properties.  It has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women.  It is approximately 5 times as potent as methyltestosterone.  No brands in Thailand. Fluoxymesterone
  • 26. 5. MESTEROLONE  Mesterolone is an orally applicable androgen, and DHT derivative.  Indication & Dose :  Reduced efficiency in middle & advanced age due to androgen deficiency  1 tab tid.  After satisfactory clinical improvement try to reduce the dose. Treatment may be continued to 1 tab once daily or bid.  Hypogonadism  Max: 1-2 tab tid for several mth.  Maintenance dose: 1 tab 2-3 times daily.  Infertility for the improvement of sperm quantity & quality  1 tab bid-tid for about 90 days & repeated after at several wk if necessary. Mesterolone
  • 27. 5. MESTEROLONE  Mesterolone had seen widespread use in bodybuilding primarily for antiestrogenic activity in anabolic steroid stacks.  Most significant benefits of current Mesterolone use are considered to be maintaining libido off-cycle and also relatively and temporarily improving vascularity. Mesterolone
  • 28. S2. EPTIDE HORMONES, GROWTH FACTORS AND RELATED SUBSTANCES  The following substances and their releasing factors are prohibited:  Erythropoiesis-Stimulating Agents  [e.g. erythropoietin (EPO), darbepoetin (dEPO), hypoxia-inducible factor (HIF) stabilizers, methoxy polyethylene glycol-epoetin beta (CERA), peginesatide (Hematide)]  Chorionic Gonadotrophin (CG) and Luteinizing Hormone (LH) in males  The importance of measuring hCG and luteinizing hormone (LH) in the control of testosterone misuse.  CG is used in sports in an attempt to avoid the hormone deficiency resulting after anabolic steroids are discontinued. The production of testosterone, suppressed by the use of anabolic agents, is stimulated once more.
  • 29. ERYTHROPOIETIN (EPO)  Treatment of anemia associated w/ chronic renal failure & in cancer patients treated w/ chemotherapy.  Erythropoiesis-stimulating agents (ESAs) have a history of use as blood doping agents in endurance sports  The overall oxygen delivery system (blood oxygen levels, as well as heart stroke volume, vascularization, and lung function) is one of the major limiting factors to muscles' ability to perform endurance exercise.  Therefore, the primary reason athletes may use ESAs is to improve oxygen delivery to muscles, which directly improves their endurance capacity.
  • 30. S2. EPTIDE HORMONES, GROWTH FACTORS AND RELATED SUBSTANCES  The following substances and their releasing factors are prohibited:  Corticotrophins  to improve strength and boost the red- blood-cell count. A high red-blood-cell count means that the blood can carry more oxygen, which helps improve performance.  Corticotrophin is used in the place of glucocorticoids following long periods of physical stress.  Growth Hormone and Growth factor group,  The effect of reducing body fat while simultaneously increasing muscle mass makes the substance prone to misuse in sports. In bodybuilding, growth hormones are combined with anabolic agents, which further exacerbates the risk involved in both substance types.
  • 31. S3. BETA-2 AGONISTS  All beta-2 agonists, including all optical isomers (e.g. d- and l-) where relevant, are prohibited except  inhaled salbutamol (maximum 1600 micrograms over 24 hours),  inhaled formoterol (maximum delivered dose 54 micrograms over 24 hours) and  salmeterol when taken by inhalation in accordance with the manufacturers’ recommended therapeutic regimen.
  • 32. S3. BETA-2 AGONISTS Inhaled salbutamol Inhaled formoterol Salmeterol
  • 33. S3. BETA-2 AGONISTS  Effects:  Beta-2 agonists have the effect of relaxing the bronchial muscles by stimulating the beta-2 receptors.  In this way they alleviate the symptoms of an asthma attack.  Medical use:  Beta-2 agonists are used in medicine to treat bronchial asthma.  A distinction is made between short- acting substances, which are inhaled especially during an asthma attack, and long-acting beta-2 agonists that are used in basic therapy to reduce the susceptibility of muscles to cramps.
  • 34. S3. BETA-2 AGONISTS  Misuse in sports:  When administered in high doses, these substances promote protein synthesis, which in the case of animals resulted in an increase in the proportion of muscle mass to fat mass.  Athletes using these substances for doping anticipate similar effects, as well as a short-term enhancement of performance due to the dilation of bronchial passages.  Some beta-2 agonists are prohibited in sports. In some cases therapy for medical reasons must be approved by applying for a therapeutic use exemption (TUE).
  • 35. OTHER  S4. HORMONE AND METABOLIC MODULATORS  S5. DIURETICS AND OTHER MASKING AGENTS
  • 36. WARNING SIGNS OF COMMONLY ABUSED DRUGS  Marijuana: Glassy, red eyes; loud talking, inappropriate laughter followed by sleepiness; loss of interest, motivation; weight gain or loss.  Depressants (including Xanax, Valium, GHB): Contracted pupils; drunk-like; difficulty concentrating; clumsiness; poor judgment; slurred speech; sleepiness.  Stimulants (including amphetamines, cocaine, crystal meth): Dilated pupils; hyperactivity; euphoria; irritability; anxiety; excessive talking followed by depression or excessive sleeping at odd times; may go long periods of time without eating or sleeping; weight loss; dry mouth and nose.  Inhalants (glues, aerosols, vapors): Watery eyes; impaired vision, memory and thought; secretions from the nose or rashes around the nose and mouth; headaches and nausea; appearance of intoxication; drowsiness; poor muscle control; changes in appetite; anxiety; irritability; lots of cans/aerosols in the trash.  Hallucinogens (LSD, PCP): Dilated pupils; bizarre and irrational behavior including paranoia, aggression, hallucinations; mood swings; detachment from people; absorption with self or other objects, slurred speech; confusion.  Heroin: Contracted pupils; no response of pupils to light; needle marks; sleeping at unusual times; sweating; vomiting; coughing, sniffling; twitching; loss of appetite.